| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |